¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023 ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2023-09-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023 ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2023-09-02
±³À°ÀÏÀÚ : 2023-09-02
±³À°Àå¼Ò : ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀǽÇ

±³À°ÁÖÁ¦ : 2023 ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°

ÁÖÃÖ±â°ü : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ
´ã´çÀÚ : ±èÁø¿Á
¿¬¶ôó : 010-2563-6902

À̸ÞÀÏ : ksbtp.svc@gmail.com

±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 12 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 40,000¿ø  

ºñ°í Àü¹®ÀÇ 40,000¿ø (ÇöÀåµî·Ï 50,000¿ø)±ºÀü¹®ÀÇ, °øº¸ÀÇ, Àü°øÀÇ 20,000¿ø (ÇöÀåµî·Ï 30,000¿ø)Æò»ýȸ¿ø ¸éÁ¦ (ÇöÀåµî·Ï 10,000¿ø)


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 09:40~10:05 What we learn about bipolar disorder from large-scale neuroimaging ±è°æ¿ø(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 10:05~10:30 Global neuroimaging studies of MDD through worldwide data sharing À±¼®È£(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 10:30~10:55 Cross-disorder comparison of major neuropsychiatric disorder ±èº´ÈÆ(¿¬¼¼ÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 10:55~11:05 Q&A ( )

ÈÞ½Ä 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 11:05~11:15 CoffeeBreak ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 11:15~11:40 An update of Cortico-Striato-Thalamo-Cortical (CSTC) loop underlying OCD ±èÁÖ¿Ï(Àü³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 11:40~12:05 Neuroimaging findings of traditional and third-wave CBT in OCD ÀÌ»ó¿ø(°æºÏÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 12:05~12:30 Integrative understanding of functional brain network underlying OCD À̽ÂÀç(°æºÏÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 12:30~12:40 Q&A ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 12:40~13:40 Anti-anxiety effect of olanzapine À̽ÂÀç(°æºÏÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 13:40~14:05 ATN classification of Alzheimer¡¯s disease and diagnostic biomarkers °ø³ª¿µ(°è¸íÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 14:05~14:30 Disease-modifying therapy for Alzheimer¡¯s disease Àü¼Ò¿¬(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 14:30~14:55 The role of cognitive intervention and digital therapeutics ±èÇý±Ý(¿µ³²ÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 14:55~15:05 Q&A ( )

ÈÞ½Ä 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 15:05~15:15 CoffeeBreak ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 15:15~15:40 Substance use trend in Korean adolescent: epidemiology and fact sheet ±èÁØ¿ø(´ë±¸ °¡Å縯ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 15:40~16:05 Fentanyl use: clinical manifestations, medical and psychopharmacological treatment Á¶¼ÒÇý(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 16:05~16:30 Psychosocial treatment of substance use disorder in adolescent. ÀÌÈ£ÁØ(°è¸íÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç A·ë 16:30~16:40 Q&A ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 09:40~10:05 Emotion recognition deficits in psychiatric disorder ¹é¼±È­(Àü³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 10:05~10:30 Present and near future of emotion recognition ¾çÇüÁ¤(Àü³²´ë ÀΰøÁö´ÉÇкÎ)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 10:30~10:55 Intervention of psychiatric disorder using ICT & emotion recognition ±è½Â¿ø(Àü³²´ë ÀΰøÁö´ÉÇкÎ)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 10:55~11:05 Q&A ( )

ÈÞ½Ä 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 11:05~11:15 CoffeeBreak ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 11:15~11:40 Overview of CIAS ±è¼ºÁø(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 11:40~12:05 Pharmacologic interventions of CIAS ±è¼­¿µ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 12:05~12:30 Nonpharmacologic interventions of CIAS Á¤µµ¿î(ÀÎÁ¦ÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 12:30~12:40 Q&A ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 13:40~14:15 ChatGPT: Artificial Intelligence & Mental Health Ȳ½Â¿ø(¼­¿ï´ë ÄÄÇ»ÅÍ°øÇкÎ)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 14:15~14:20 Q&A ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 14:20~15:00 ChatGPT and the Future of Medical Writing ¾È»óÁø(ÀÎÁ¦ÀÇ´ë ¾à¸®ÇÐ)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 15:00~15:05 Q&A ( )

ÈÞ½Ä 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 15:05~15:15 CoffeeBreak ( )

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 15:15~15:40 Tardive dyskinesia and valbenazine Á¤Áö¿î(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 15:40~16:05 Parkinson ±èÇö¼ö(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 16:05~16:30 Depression and dextromethorphan/buproprion Àå½ÂÈ£(¿ø±¤ÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ ±¤ÁÖ ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ 2Ãþ ȸÀÇ½Ç B·ë 16:30~16:40 Q&A ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023 ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2023-09-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¿ø±¤½ÉÀå½ÉÆ÷Áö¿ò(Wonkwang Cardiology Conference: WCC 2023) : 2023-09-02
´ÙÀ½±Û ¼¼ºê¶õ½ºº´¿ø ÈäºÎ¿Ü°ú YONSEI WORKSHOP ON ESOPHAGEAL CANCER 2023 : 2023-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21062 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(4ÀÏÂ÷) : 2024-07-04 0 120 2024-06-18
21061 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ÀçÅÃÀÇ·á ȯÀÚ Áø·áÀÇ ½ÇÁ¦ : 2024-07-04 0 71 2024-06-18
21060 ¿ï»ê ´ëÇÑ»êºÎÀΰúÀÇ»çȸ ¿ï»êÁöȸ ¿¬¼ö±³À°(¿ù°æÅë, µ¥³ë¼ö¹ä Áß´Ü ÈÄ ¹Ýµ¿°ñÀýÀÇ ¿¹¹æ) : 2024-07-04 0 98 2024-06-18
21059 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(3ÀÏÂ÷) : 2024-07-03 0 20 2024-06-18
21058 °æ±â 2024³â ÆòÅýÃÀÇ»çȸ ÇÏ°èÇмú´ëȸ : 2024-07-02 0 110 2024-06-18
21057 ¼­¿ï ¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(2ÀÏÂ÷) : 2024-07-02 0 83 2024-06-18
21056 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-01 0 64 2024-06-18
21055 ¼­¿ï (¿Â¶óÀÎ)¹ÙÀÌ¿Àºòµ¥ÀÌÅÍÀÇ È°¿ë°ú ÃֽŠ¿ªÇÐ ¼³°è ¹× ±â°èÇнÀ(1ÀÏÂ÷) : 2024-07-01 0 63 2024-06-18
21054 ÃæºÏ ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ Understanding Current Community Mental Health and Emotional Disorders in ASD : 2024-07-01 0 93 2024-06-18
21053 ¼­¿ï (¿Â¶óÀÎ) 2024³âµµ °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 59 2024-06-18
21052 °æ±â ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦2ȸ CHAMS °³¿øÀÇ ½ÉÆ÷Áö¾ö : 2024-06-30 0 64 2024-06-18
21051 ¼­¿ï 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ¼­¿ïÁöȸ Çϰ迬¼ö°­Á : 2024-06-30 0 78 2024-06-18
21050 ºÎ»ê 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-30 0 35 2024-06-18
21049 ¼­¿ï Á¦26Â÷ ´ëÇѾƵ¿º´¿øÇùȸ Ãá°èÇмú´ëȸ : 2024-06-30 0 26 2024-06-18
21048 Ãæ³² 2024 ÀÌ°úÇÐ ¿¬±¸¼¼¹Ì³ª : 2024-06-29 0 27 2024-06-18
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷